PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 22, 2026Digestive and Liver Disease0 citationsOpen Access

Health inequalities in patients with cirrhosis: Investigating the impact of material deprivation on patients’ outcomes

APAndrea PastaDRDiletta Maria RossiSLSara Labanca

Key Points

  • To assess how material deprivation influences clinical outcomes in patients with cirrhosis within a universal healthcare system.
  • Retrospective analysis of cirrhosis patients from 2016-2022
  • Classified material deprivation based on residential address
  • Dichotomized material deprivation into low and high using cluster analysis
  • Evaluated diagnosis modality, disease stage, follow-up adherence, and hospitalization rates
  • 368 patients studied, with high male representation (68.5%) and median age of 63 years
  • Patients with low material deprivation were older and more frequently diagnosed through screening
  • Higher hospitalization rates for hepatic decompensation in high material deprivation group (IRR: 1.95)
  • Overall survival shorter in high material deprivation group (66.2 months vs. 93.7 months)

Abstract

AbstractBackground Material deprivation (MD) is a key social determinant that may influence outcomes in cirrhosis, although its effect remains underdefined. Aims To assess the impact of MD on clinical outcomes in patients with cirrhosis in a universal healthcare setting. Methods We retrospectively studied patients with cirrhosis residing in Genoa, first attending our Unit during 2016-2022, classified MD from residential address by prespecified criteria, and dichotomized MD into low and high via cluster analysis; we assessed modality of cirrhosis diagnosis, disease stage, follow-up adherence, hepatic decompensation requiring hospitalization, and overall survival. Results We studied 368 patients (68.5% male, median age 63 years), most with compensated disease (57.9%). Patients with low-MD were slightly older (64 years vs. 62 years; pvs. 14.4%; pvs. 15.5%; pvs. 93.7 months, CI 83.5–103.5) in patients with high-MD. Conclusion MD significantly impacts clinical outcomes in patients with cirrhosis and is associated with worse prognosis, despite universal coverage.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Pasta et al. (2026) studied this question.

synapsesocial.com/papers/699a9cc6482488d673cd27cchttps://doi.org/10.1016/j.dld.2026.01.225
Ask AI
Helpful
Bookmark
Share
View Full Paper